======= EHMT1 =======
== Gene Information ==
* **Official Symbol**: EHMT1
* **Official Name**: euchromatic histone lysine methyltransferase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79813|79813]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H9B1|Q9H9B1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EHMT1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EHMT1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607001|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017].
* **UniProt Summary**: Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non- histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. {ECO:0000269|PubMed:12004135, ECO:0000269|PubMed:20118233}.
|SET|
|Pre-SET|
|Ank|
|Ank 2|
|histone methyltransferase activity (H3-K27 specific)|
|histone methyltransferase activity (H3-K9 specific)|
|response to fungicide|
|peptidyl-lysine monomethylation|
|histone H3-K27 methylation|
|peptidyl-lysine dimethylation|
|C2H2 zinc finger domain binding|
|histone H3-K9 methylation|
|histone-lysine N-methyltransferase activity|
|histone H3-K9 modification|
|protein-lysine N-methyltransferase activity|
|negative regulation of G0 to G1 transition|
|regulation of G0 to G1 transition|
|DNA methylation|
|DNA alkylation|
|methyltransferase activity|
|DNA methylation or demethylation|
|p53 binding|
|histone lysine methylation|
|DNA modification|
|peptidyl-lysine methylation|
|histone methylation|
|positive regulation of cold-induced thermogenesis|
|chromosome|
|regulation of embryonic development|
|protein alkylation|
|protein methylation|
|regulation of cold-induced thermogenesis|
|regulation of signal transduction by p53 class mediator|
|macromolecule methylation|
|nuclear body|
|response to antibiotic|
|methylation|
|peptidyl-lysine modification|
|negative regulation of cell cycle process|
|histone modification|
|covalent chromatin modification|
|response to toxic substance|
|negative regulation of cell cycle|
|chromatin organization|
|DNA metabolic process|
|regulation of cell cycle process|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|peptidyl-amino acid modification|
|chromosome organization|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
|positive regulation of multicellular organismal process|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp467|CAY10603 0.55μM R08 exp467]]|1.79|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.92|
|[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.44|
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.64|
^Gene^Correlation^
|[[:human genes:e:ehmt2|EHMT2]]|0.409|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1858
* **Expression level (log2 read counts)**: 6.89
{{:chemogenomics:nalm6 dist.png?nolink |}}